Innate Pharma to Participate in Upcoming June 2023 Investor Conferences

BIOMARKER

Gray Frame Corner
Gray Frame Corner

1. Innate Pharma will participate in the American Society for Clinical Oncology (ASCO) 2023 Annual Meeting, scheduled for June 2-5 in Chicago (USA).

Gray Frame Corner
Gray Frame Corner

2. They will also be present at the Jefferies Healthcare Conference 2023, taking place on June 7-9 in New York (USA).

Gray Frame Corner
Gray Frame Corner

3. Innate Pharma's senior management team will attend the Goldman Sachs 44th Annual Global Healthcare Conference, held from June 12-15 in Dana Point (USA).

Gray Frame Corner
Gray Frame Corner

4. The company will be represented at the Stifel European Healthcare Summit 2023, which will be held in Bordeaux (France) from June 28-30.

Gray Frame Corner
Gray Frame Corner

5. Innate Pharma is a global, clinical-stage biotechnology company focused on developing immunotherapies for cancer patients.

Gray Frame Corner
Gray Frame Corner

6. Their innovative approach utilizes therapeutic antibodies and their proprietary ANKET® platform (Antibody-based NK cell Engager Therapeutics) to harness the innate immune system.

Gray Frame Corner
Gray Frame Corner

7. Innate Pharma's portfolio includes lead programs such as lacutamab for advanced cutaneous T cell lymphomas and peripheral T cell lymphomas, and monalizumab developed in collaboration with AstraZeneca for non-small cell lung cancer.

Gray Frame Corner
Gray Frame Corner

8. The company is also developing ANKET® multi-specific NK cell engagers to target multiple tumor types.

Gray Frame Corner
Gray Frame Corner

9. Innate Pharma collaborates with biopharmaceutical companies like Sanofi and AstraZeneca, as well as leading research institutions, to advance innovation and research for the benefit of patients.

Gray Frame Corner
Gray Frame Corner

10. Headquartered in Marseille, France, with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq stock exchanges.

Gray Frame Corner
Gray Frame Corner

Swipe up for more BIOMARKER news!